6MW3511 in Patients With Advanced Solid Tumor
Clinical trial NCT05524194 · UNKNOWN
Trial details
- NCT number
- NCT05524194
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-06-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.